title: Routine bivalirudin use in percutaneous carotid interventions.
authors.forename: Ruth L
authors.initials: RL
authors.lastname: Bush
authors.forename: Peter H
authors.initials: PH
authors.lastname: Lin
authors.forename: Leila
authors.initials: L
authors.lastname: Mureebe
authors.forename: Wei
authors.initials: W
authors.lastname: Zhou
authors.forename: Eric K
authors.initials: EK
authors.lastname: Peden
authors.forename: Alan B
authors.initials: AB
authors.lastname: Lumsden
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D016893:Carotid Stenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D002404:Catheterization / Q000295:instrumentation / Q000379:methods*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006629:Hirudins; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D015607:Stents; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin